Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2004

01-11-2004 | Article

Delayed maturation of IgG avidity in congenital toxoplasmosis

Authors: W. Buffolano, M. Lappalainen, L. Hedman, F. Ciccimarra, M. Del Pezzo, R. Rescaldani, N. Gargano, K. Hedman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2004

Login to get access

Abstract

The aim of this comparative study was to investigate the clinical usefulness of the measurement of Toxoplasma gondii IgG avidity in the postnatal diagnosis of congenital toxoplasmosis. IgG avidity values in serum samples from infants with congenital infection were compared with those in samples from uninfected infants, all born to mothers with toxoplasmosis acquired during gestation. This analysis revealed that IgG avidity values soon after birth reflected maternal values in the large majority of the samples. Low or borderline IgG avidity values were systematically found in the cohort of congenitally infected subjects. After birth, IgG avidity values slowly increased over time for up to 2 years in congenitally infected subjects. On the contrary, IgG avidity values in the uninfected infants remained stable over time. The presence of low IgG avidity in a newborn can be considered a marker of maternal seroconversion in the second or third trimester of gestation and, as a consequence, an indicator of risk for congenital toxoplasmosis. An IgG avidity assay can be easily carried out with antibodies eluted from dried blood spots (Guthrie cards), providing an opportunity to retrospectively evaluate the risk of congenital infection in special clinical circumstances, for example when suspicion of congenital infection arises during late infancy.
Literature
1.
go back to reference Remington JS, McLeod R, Desmonts G (2000) Toxoplasmosis. In: Remington JS, Klein JO (eds) Infectious diseases of the foetus and newborn infant, 5th edn. Saunders, Philadelphia, pp 205–346 Remington JS, McLeod R, Desmonts G (2000) Toxoplasmosis. In: Remington JS, Klein JO (eds) Infectious diseases of the foetus and newborn infant, 5th edn. Saunders, Philadelphia, pp 205–346
2.
go back to reference Koppe JG, Loewer-Sieger DH, De Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 101:254–257CrossRef Koppe JG, Loewer-Sieger DH, De Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 101:254–257CrossRef
3.
go back to reference Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynaecol 180:410–415 Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynaecol 180:410–415
4.
go back to reference Petersen E, Pollak A, Reiter-Owona I (2001) Recent trends in research on congenital toxoplasmosis. Int J Parasitol 31:115–144CrossRefPubMed Petersen E, Pollak A, Reiter-Owona I (2001) Recent trends in research on congenital toxoplasmosis. Int J Parasitol 31:115–144CrossRefPubMed
5.
go back to reference Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE (1999) Mother to child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 353:1829–1833CrossRefPubMed Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE (1999) Mother to child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 353:1829–1833CrossRefPubMed
6.
go back to reference Hohlfeld P, Daffos F, Costa JM, Thuillez PH, Forestier F, Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. New Engl J Med 331:695–699CrossRefPubMed Hohlfeld P, Daffos F, Costa JM, Thuillez PH, Forestier F, Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. New Engl J Med 331:695–699CrossRefPubMed
7.
go back to reference Congenital toxoplasmosis (2003) European Symposium on Congenital Toxoplasmosis. Arch Pediatr 10:1–48 Congenital toxoplasmosis (2003) European Symposium on Congenital Toxoplasmosis. Arch Pediatr 10:1–48
8.
go back to reference Buffolano W, Sagliocca L, Fratta D, Tozzi A, Cardone A, Binkin N (1994) Prenatal toxoplasmosis screening in Campania region of Italy. It J Gynaecol Obstet 3:70–74 Buffolano W, Sagliocca L, Fratta D, Tozzi A, Cardone A, Binkin N (1994) Prenatal toxoplasmosis screening in Campania region of Italy. It J Gynaecol Obstet 3:70–74
9.
go back to reference Nassens A, Jenum P, Pollak A, Decoster A, Lappalainen M, Villena I, Lebech M, Stray-Pedersen B, Hayde M, Pinon JM, Petersen E, Foulon W (1999) Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 135:714–719PubMed Nassens A, Jenum P, Pollak A, Decoster A, Lappalainen M, Villena I, Lebech M, Stray-Pedersen B, Hayde M, Pinon JM, Petersen E, Foulon W (1999) Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 135:714–719PubMed
10.
go back to reference Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, Zufferey J, Bessieres MH, Marty P, Holliman R, Johnson J, Luyasu V, Lecolier B, Guy E, Joynson DH, Decoster A, Enders G, Pelloux H, Candolfi E (2001) Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 39:2267–2271CrossRefPubMed Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, Zufferey J, Bessieres MH, Marty P, Holliman R, Johnson J, Luyasu V, Lecolier B, Guy E, Joynson DH, Decoster A, Enders G, Pelloux H, Candolfi E (2001) Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 39:2267–2271CrossRefPubMed
11.
go back to reference Hedman K, Lappalainen M, Seppala I, Makela O (1989) Recent primary Toxoplasma gondii infection indicated by a low avidity of specific IgG. J Infect Dis 159:736–740PubMed Hedman K, Lappalainen M, Seppala I, Makela O (1989) Recent primary Toxoplasma gondii infection indicated by a low avidity of specific IgG. J Infect Dis 159:736–740PubMed
12.
go back to reference Jenum PA, Stray-Pedersen B, Gundersen AG (1997) Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 35:1972–1977PubMed Jenum PA, Stray-Pedersen B, Gundersen AG (1997) Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 35:1972–1977PubMed
13.
go back to reference Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS (2001) Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a U.S. reference laboratory. J Infect Dis 183:1248–1253CrossRefPubMed Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS (2001) Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a U.S. reference laboratory. J Infect Dis 183:1248–1253CrossRefPubMed
14.
go back to reference Roberts A, Hedman K, Luyasu V, Zufferey J, Bessieères MH, Blatz RM, Candolfi E, Decoster A, Enders G, Gross U, Guy E, Hayde M, Ho-Yen D, Johnson J, Lecolier B, Nassens A, Pelloux H, Thulliez P, Petersen E (2001) Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 20:467–474CrossRefPubMed Roberts A, Hedman K, Luyasu V, Zufferey J, Bessieères MH, Blatz RM, Candolfi E, Decoster A, Enders G, Gross U, Guy E, Hayde M, Ho-Yen D, Johnson J, Lecolier B, Nassens A, Pelloux H, Thulliez P, Petersen E (2001) Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 20:467–474CrossRefPubMed
15.
go back to reference Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E (1996) Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 15:799–805PubMed Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E (1996) Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 15:799–805PubMed
16.
go back to reference Hohlfeld P, Daffos F, Thulliez PH, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F (1989) Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115:765–769PubMed Hohlfeld P, Daffos F, Thulliez PH, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F (1989) Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115:765–769PubMed
17.
go back to reference Lebech M, Petersen E (1999) Neonatal screening for Toxoplasma infection. Lancet 354:1030–1031PubMed Lebech M, Petersen E (1999) Neonatal screening for Toxoplasma infection. Lancet 354:1030–1031PubMed
18.
go back to reference Korhonen MH, Brunstein J, Haario H, Katnikov A, Rescaldani R, Hedman K (1999) A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol 6:725–728PubMed Korhonen MH, Brunstein J, Haario H, Katnikov A, Rescaldani R, Hedman K (1999) A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol 6:725–728PubMed
19.
go back to reference Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J (1999) Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol 37:2893–2898PubMed Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J (1999) Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol 37:2893–2898PubMed
20.
go back to reference 20. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, et al (1994) Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 330:1858–1863CrossRef 20. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, et al (1994) Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 330:1858–1863CrossRef
21.
go back to reference Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Norgaard-Pedersen B, Petersen E (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353:1834–1837CrossRefPubMed Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Norgaard-Pedersen B, Petersen E (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353:1834–1837CrossRefPubMed
22.
go back to reference Paul M, Petersen E, Pawlowski ZS, Szczapa J (2000) Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 19:30–36CrossRefPubMed Paul M, Petersen E, Pawlowski ZS, Szczapa J (2000) Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 19:30–36CrossRefPubMed
23.
go back to reference Pelloux H, Brun E, Vernet G, Marcillat S, Jolivet M, Guergour D, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P (1998) Determination of anti- Toxoplasma gondii immunoglobulin G avidity; adaptation to the Vidas system (bioMérieux). Diagn Microbiol Infect Dis 32:69–73CrossRefPubMed Pelloux H, Brun E, Vernet G, Marcillat S, Jolivet M, Guergour D, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P (1998) Determination of anti- Toxoplasma gondii immunoglobulin G avidity; adaptation to the Vidas system (bioMérieux). Diagn Microbiol Infect Dis 32:69–73CrossRefPubMed
24.
go back to reference Lappalainen M, Koskela P, Koskiniemi M, Ämmälä P, Hiilesmaa V, Teramo K, Raivio KO, Remington JS, Hedman K (1993) Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 167:691–697PubMed Lappalainen M, Koskela P, Koskiniemi M, Ämmälä P, Hiilesmaa V, Teramo K, Raivio KO, Remington JS, Hedman K (1993) Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 167:691–697PubMed
25.
go back to reference Lappalainen M, Koskiniemi M, Hilesmaa V, Ammala P, Teramo K, Koskela P, Lebech M, Raivio KO, Hedman K (1995) Outcome of children after maternal primary infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 14:354–361PubMed Lappalainen M, Koskiniemi M, Hilesmaa V, Ammala P, Teramo K, Koskela P, Lebech M, Raivio KO, Hedman K (1995) Outcome of children after maternal primary infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 14:354–361PubMed
26.
go back to reference Fitzgerald MG, Pullen GR, Hosking CS (1998) Low affinity antibody to rubella antigen in patients after rubella infection in utero. Pediatrics 81:812–814 Fitzgerald MG, Pullen GR, Hosking CS (1998) Low affinity antibody to rubella antigen in patients after rubella infection in utero. Pediatrics 81:812–814
27.
go back to reference Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, Felici F, Gargano N (2003) Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol 41:5414–5418CrossRefPubMed Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, Felici F, Gargano N (2003) Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol 41:5414–5418CrossRefPubMed
Metadata
Title
Delayed maturation of IgG avidity in congenital toxoplasmosis
Authors
W. Buffolano
M. Lappalainen
L. Hedman
F. Ciccimarra
M. Del Pezzo
R. Rescaldani
N. Gargano
K. Hedman
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1226-1

Other articles of this Issue 11/2004

European Journal of Clinical Microbiology & Infectious Diseases 11/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.